These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 28209435)
1. Contribution of equilibrative nucleoside transporter (ENT) 2 to fluorouracil transport in rat placental trophoblast cells. Takagi A; Nishimura T; Akashi T; Tomi M; Nakashima E Drug Metab Pharmacokinet; 2017 Apr; 32(2):151-156. PubMed ID: 28209435 [TBL] [Abstract][Full Text] [Related]
2. Quantification of ENT1 and ENT2 Proteins at the Placental Barrier and Contribution of These Transporters to Ribavirin Uptake. Nishimura T; Sano Y; Takahashi Y; Noguchi S; Uchida Y; Takagi A; Tanaka T; Katakura S; Nakashima E; Tachikawa M; Maruyama T; Terasaki T; Tomi M J Pharm Sci; 2019 Dec; 108(12):3917-3922. PubMed ID: 31520644 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of nucleoside uptake in rat placenta and induction of placental CNT2 in experimental diabetes. Nishimura T; Chishu T; Tomi M; Nakamura R; Sato K; Kose N; Sai Y; Nakashima E Drug Metab Pharmacokinet; 2012; 27(4):439-46. PubMed ID: 22354287 [TBL] [Abstract][Full Text] [Related]
4. Influx mechanism of 2',3'-dideoxyinosine and uridine at the blood-placenta barrier. Sato K; Sai Y; Nishimura T; Chishu T; Shimpo S; Kose N; Nakashima E Placenta; 2009 Mar; 30(3):263-9. PubMed ID: 19135251 [TBL] [Abstract][Full Text] [Related]
5. Fluorouracil uptake in triple-negative breast cancer cells: Negligible contribution of equilibrative nucleoside transporters 1 and 2. Noguchi S; Takagi A; Tanaka T; Takahashi Y; Pan X; Kibayashi Y; Mizokami R; Nishimura T; Tomi M Biopharm Drug Dispos; 2021 Mar; 42(2-3):85-93. PubMed ID: 33426680 [TBL] [Abstract][Full Text] [Related]
6. Potential of various drugs to inhibit nucleoside uptake in rat syncytiotrophoblast cell line, TR-TBT 18d-1. Chishu T; Sai Y; Nishimura T; Sato K; Kose N; Nakashima E Placenta; 2008 May; 29(5):461-7. PubMed ID: 18329095 [TBL] [Abstract][Full Text] [Related]
7. Predicting Drug Interactions with Human Equilibrative Nucleoside Transporters 1 and 2 Using Functional Knockout Cell Lines and Bayesian Modeling. Miller SR; Zhang X; Hau RK; Jilek JL; Jennings EQ; Galligan JJ; Foil DH; Zorn KM; Ekins S; Wright SH; Cherrington NJ Mol Pharmacol; 2021 Feb; 99(2):147-162. PubMed ID: 33262250 [TBL] [Abstract][Full Text] [Related]
8. 6-Mercaptopurine transport by equilibrative nucleoside transporters in conditionally immortalized rat syncytiotrophoblast cell lines TR-TBTs. Lee NY; Sai Y; Nakashima E; Ohtsuki S; Kang YS J Pharm Sci; 2011 Sep; 100(9):3773-82. PubMed ID: 21590775 [TBL] [Abstract][Full Text] [Related]
9. Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2. Miller SR; Hau RK; Jilek JL; Morales MN; Wright SH; Cherrington NJ Drug Metab Dispos; 2020 Jul; 48(7):603-612. PubMed ID: 32393653 [TBL] [Abstract][Full Text] [Related]
10. Transport of antiviral 3'-deoxy-nucleoside drugs by recombinant human and rat equilibrative, nitrobenzylthioinosine (NBMPR)-insensitive (ENT2) nucleoside transporter proteins produced in Xenopus oocytes. Yao SY; Ng AM; Sundaram M; Cass CE; Baldwin SA; Young JD Mol Membr Biol; 2001; 18(2):161-7. PubMed ID: 11463208 [TBL] [Abstract][Full Text] [Related]
11. Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites. Miller SR; McGrath ME; Zorn KM; Ekins S; Wright SH; Cherrington NJ Mol Pharmacol; 2021 Dec; 100(6):548-557. PubMed ID: 34503974 [TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain. Kiss A; Farah K; Kim J; Garriock RJ; Drysdale TA; Hammond JR Biochem J; 2000 Dec; 352 Pt 2(Pt 2):363-72. PubMed ID: 11085929 [TBL] [Abstract][Full Text] [Related]
13. Development of a Novel HEK293 Cell Model Lacking Shahid N; Cromwell C; Hubbard BP; Hammond JR Drug Metab Dispos; 2024 Sep; 52(10):1094-1103. PubMed ID: 39054074 [TBL] [Abstract][Full Text] [Related]
14. Blood-to-Testis Transport of Ribavirin Involves Carrier-Mediated Processes at the Blood-Testis Barrier. Ito T; Kubo Y; Tega Y; Akanuma SI; Hosoya KI J Pharm Sci; 2024 Aug; 113(8):2616-2624. PubMed ID: 38679231 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of human equilibrative nucleoside transporters by 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine. Tang PCT; Yang C; Li RW; Lee SM; Hoi MP; Chan SW; Kwan YW; Tse CM; Leung GP Eur J Pharmacol; 2016 Nov; 791():544-551. PubMed ID: 27388143 [TBL] [Abstract][Full Text] [Related]
16. Multiple Drug Transporters Contribute to the Placental Transfer of Emtricitabine. Zeng Q; Bai M; Li C; Lu S; Ma Z; Zhao Y; Zhou H; Jiang H; Sun D; Zheng C Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31160284 [TBL] [Abstract][Full Text] [Related]